·finance.yahoo.comLow
Paysign: 3 Key Takeaways for Long-Term Investors
Paysign reports $34.5M in cash, no bank debt, and plans to invest in high-margin features and core operations. CEO Mark Newcomer expects strong year-over-year growth.
StockNASDAQ · US · USDTechnology · Software - Infrastructure
$PAYS
Paysign, Inc.
Paysign provides prepaid card products and processing services for corporate, consumer and government customers, and life science technology solutions for blood and plasma collection organizations. Its Paysign-branded offerings include corporate incentives, expense and travel cards, consumer rebates, donor compensation, pharmaceutical patient assistance, healthcare payments, prepaid gift cards and reloadable debit cards. Apherion is its cloud-based software platform for blood and plasma collection organizations. Paysign manages prepaid card programs across the card lifecycle, including processing, enrollment, card production, account management and customer service. It earns fees from cardholder activity, interchange, program management, claims processing, licensing, hosting and consulting, as well as breakage and settlement income. Its cards are issued through bank partners. Paysign is headquartered in Nevada.
AlphAI earnings readQ3 FY2026 · NOV 9Paysign Q3 2026 revenue up 42.6% to $30.80 million; operating margin 23.8%; FY2026 gross margin, net income, GAAP diluted EPS and Adjusted EBITDA guidance raisedVerdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $PAYSvia TradingView
AI sentiment · 7d9 articles
- Bullish
- 9
- Neutral
- 0
- Bearish
- 0
Insider · 30dAll trades →
No SEC Form 4 filings for $PAYS in the last 30 days.
See all $PAYS insider activity →Top stories · $PAYSMore →
·tradingview.com
Ladenburg Thalmann maintains PaySign at Buy, raises price target to $15.25 from $14
Ladenburg Thalmann maintained its Buy rating on PaySign and raised its price target to $15.25 from $14, an 8.9% increase. This implies a 50.4% upside from the Nov 10 close of $10.14.
·tradingview.com
Maxim Group downgrades PaySign to Hold from Buy
Maxim Group downgraded PaySign Inc. from Buy to Hold. The firm did not provide a new price target. This change in rating may impact investor sentiment and trading activity for the company's shares.
PAYS sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 9 news stories mentioning PAYS (Paysign, Inc.). Coverage has skewed bullish: 9 bullish, 0 neutral, and 0 bearish.
Recent PAYS coverage spans financial news, insider activity and earnings.
What's driving PAYS
Paysign reports $34.5M in cash, no bank debt, and plans to invest in high-margin features and core operations. CEO Mark Newcomer expects strong year-over-year growth.
Ladenburg Thalmann maintained its Buy rating on PaySign and raised its price target to $15.25 from $14, an 8.9% increase. This implies a 50.4% upside from the Nov 10 close of $10.14.
Maxim Group downgraded PaySign Inc. from Buy to Hold. The firm did not provide a new price target. This change in rating may impact investor sentiment and trading activity for the company's shares.
DA Davidson kept PaySign's rating at Buy but reduced its price target from $15 to $14, a 6.7% cut. This implies a 38.1% upside from the Nov 10 close of $10.14, according to the firm.
Strong earnings beat guidance and higher margins suggest upward price pressure.
AlphAI scores every news story that mentions PAYS with an AI model for sentiment and relevance, and aggregates insider trades from Paysign, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $PAYS
Score
Paysign: 3 Key Takeaways for Long-Term Investors
Paysign reports $34.5M in cash, no bank debt, and plans to invest in high-margin features and core operations. CEO Mark Newcomer expects strong year-over-year growth.
Ladenburg Thalmann maintains PaySign at Buy, raises price target to $15.25 from $14
Ladenburg Thalmann maintained its Buy rating on PaySign and raised its price target to $15.25 from $14, an 8.9% increase. This implies a 50.4% upside from the Nov 10 close of $10.14.
Maxim Group downgrades PaySign to Hold from Buy
Maxim Group downgraded PaySign Inc. from Buy to Hold. The firm did not provide a new price target. This change in rating may impact investor sentiment and trading activity for the company's shares.
DA Davidson maintains PaySign at Buy, lowers price target to $14 from $15
DA Davidson kept PaySign's rating at Buy but reduced its price target from $15 to $14, a 6.7% cut. This implies a 38.1% upside from the Nov 10 close of $10.14, according to the firm.
Paysign (PAYS) Q3 2026 Earnings Call Transcript
Paysign (PAYS) reported Q3 2026 earnings, highlighting growth in its patient affordability business with revenue doubling to $16.6M YoY. Plasma revenue rose 7.5% to $13.8M. The company expects to offset a loss of 113 plasma centers with new clients. Patient affordability drove strong margins and operating leverage, while Apherion, a plasma industry software, is under regulatory review.
Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%
Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8% Patient Affordability Growth Drives Revenue and Margin Expansion Raises Full Year 2026 Gross Margin, Net Income, GAAP EPS and Adju
Newcomer Mark sold $767K of PAYS
Newcomer Mark (CEO) sold 50,000 shares of Paysign, Inc. (PAYS) at $15.34 ($0.77M total) on 2026-10-09 under a Rule 10b5-1 trading plan.
Herman Joan M sold $717K of PAYS
Herman Joan M (EVP, Operations) sold 59,904 shares of Paysign, Inc. (PAYS) at an average of $11.97 ($11.74–$12.38, $0.72M total) across 2 trades over 2026-09-15 to 2026-09-16 under a Rule 10b5-1 trading plan.
Ngo Michael C sold $1.9M of PAYS (indirect holdings)
Ngo Michael C (Chief Innovation Officer) sold 150,000 indirectly-held shares of Paysign, Inc. (PAYS) at an average of $12.79 ($12.74–$12.85, $1.92M total) across 2 trades over 2026-09-08 to 2026-09-09.
Baker Jeffery Bradford sold $442K of PAYS
Baker Jeffery Bradford (Chief Financial Officer) sold 35,000 shares of Paysign, Inc. (PAYS) at $12.62 ($0.44M total) on 2026-08-12.